Ana Bouchet
co-founder and CEO of Lifesome Therapeutics
Amatulla Nashikwala
Partnerships Officer
BASE Facility, The University of Queensland
Hossam Tayeb
Associate Professor of Biotechnology and Nanomedicine, Director of the CIPM_KAU Center of Innovation in Personalized Medicine), King AbdulAziz University, Saudi Arabia.
Soon more
Soon more
Padma Kodukula
Chief Executive Officer, ScopeSys Inc.
Audrey Nsamela
PhD, Chief Scientific Officer of Inside Therapeutics
Brendan Darby
PhD, Chief Executive Officer of Marama Labs
Olga Fontanellaz
co-founder and CEO of INCAPTEK
Jan Brummund
Business Development Director at Nanofarm Finland Plc
Christian Dubiella
Global Program Manager at CDMO (WACKER)
Carlos Victor Montefusco Pereira
PhD, Freelance Consultant, Researcher in Clinical Trial Analytics at Hasso Plattner Institute, ex BioNTech, ex Boehringer Ingelheim
Matthias Wacker
Professor of Biopharmaceutics, KU Leuven
Gaurav Goyal
CEO of Nanolyze
Khair Alhareth
Associate Professor of Pharmaceutical Technology, Université Paris Cité
Maya Thanou
Prof in Pharmaceutical Nanotechnology
Marius Schmid
CEO of ZentriForce Pharma Research GmbH
Boris Sevarika
Founder & CEO of NanoZymeX
Yosi Shamay
Associate Professor and Vice Dean for Undergraduate Studies Faculty of Biomedical Engineering, Technion - Israel Institute of Technology
Blerina Shkodra
Chief Scientific Officer at leon-nanodrugs GmbH
Nadia Lengweiller
R&D Manufacturing Engineer
Raymond Schiffelers
Professor of Nanomedicine, UMC Utrecht, VP Preclinical R&D Nanocell Therapeutics
Maria de la Fuente Freire
MBA. CEO/CSO DIVERSA Technologies SL PI of the Nano-Oncology and Translational Therapeutics Group, IDIS, SERGAS, Spain
Zhenghong Gao
Co-founder and COO at Uni-Pioneers, BioMed, Inc. and CSO at Zhongmou Therapeutics / Augelux Therapeutics (HK)
Dimitri Aubert
CEO of Vesiculab Ltd.